COVID-19 session to kick off ENDO Online 2020

Expert panel to explore pandemic’s impact on endocrine patients, care
1-Jun-2020 1:05 PM EDT, by Endocrine Society

Newswise — WASHINGTON—ENDO Online 2020—the Endocrine Society’s largest-ever meeting—will open with a panel discussion exploring the COVID-19 pandemic’s impact on the endocrinology field.

The virtual meeting will run from June 8-22 and feature both on-demand and live content. More than 19,000 attendees have registered for the event.

“COVID-19 is altering many aspects of our work as endocrine clinicians and researchers,” said session co-chair John Newell-Price, M.A., Ph.D., F.R.C.P., Chair of Endocrinology and Honorary Consultant Physician, The University of Sheffield, U.K.. “By pooling our knowledge and expertise, we can ensure our patients receive the best possible care during the pandemic.”

The live panel session, “Endocrinology in the Age of COVID-19, will feature three international speakers sharing their perspectives on how the pandemic is affecting patient care. The panel will discuss mitigating COVID-19 risks for individuals with diabetes and obesity, best practices for managing individuals with COVID-19 and diabetes, and how the disease affects individuals with adrenal insufficiency.

The speakers include: 

  • Manuel Puig-Domingo, M.D., Ph.D., Hospital Universitari Germans Trias in Pujol, Spain 
  • Endocrine Reviews Editor-in-Chief Daniel J. Drucker, M.D.of Mount Sinai Hospital in Toronto, Canada
  • Wiebke Arlt, M.D., D.Sc., F.R.C.P., F.Med.Sci.of the University of Birmingham, U.K.  

The panel will be moderated by the session’s co-chairsNewell-Price and Andrea Giustina, M.D., Professor and Chair of Endocrinology and Metabolism and Director, Postgraduate School of Endocrinology and Metabolic Diseases at San Raffaele Vita-Salute University in Milan, Italy. The session will be held June 8 at 10 a.m. Eastern. ENDO Online 2020 attendees will be able to ask questions live via chat.

The session was developed in collaboration with the European Society of Endocrinology.

ENDO Online 2020 will feature an entire day dedicated to basic science sessions on reproduction, diabetes and obesity, nuclear receptor biology, and pituitary and adrenal physiology, among other topics. Donald P. McDonnell, Ph.D., whose nuclear receptor ligands research spurred the development of a new generation of drugs for the treatment of hormone-dependent cancers and metabolic disease, will be delivering the keynote on June 9.

The ENDO Online 2020 schedule is available at https://www.endocrine.org/meetings-and-events/endo-online-2020/schedule-at-a-glance. The Society is offering complimentary registration for this year’s event to support those affected by COVID-19.

# # #

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia. 




Filters close

Showing results

110 of 4219
Released: 4-Dec-2020 4:30 PM EST
New review confirms disproportionate impact of COVID-19 on Black, Hispanic populations
Oregon Health & Science University

Black and Hispanic populations are disproportionately affected by COVID-19, according to a systematic review published this week.

Newswise: 250647_web.jpg
Released: 4-Dec-2020 4:05 PM EST
For nationalistic regimes, similar COVID-19 policies are the sincerest form of flattery
University of Texas at Arlington

Analysis from a University of Texas at Arlington assistant professor of public policy suggests that nationalistic governments around the globe are more likely to copy other nationalistic governments in responding to the current pandemic.

Released: 4-Dec-2020 3:15 PM EST
New Study Finds Once Hospitalized, Black Patients with COVID-19 Have Lower Risk of Death than White Patients
NYU Langone Health

A team of investigators at NYU Langone Health has found that once hospitalized, Black patients (after controlling for other serious health conditions and neighborhood income) were less likely to have severe illness, die, or be discharged to hospice compared to White patients.

Released: 4-Dec-2020 2:35 PM EST
AANA Commends CDC on Prioritizing COVID-19 Vaccine Distribution to Healthcare Personnel
American Association of Nurse Anesthetists (AANA)

The American Association of Nurse Anesthetists (AANA) commends the U.S. Centers for Disease Control and Prevention’s (CDC's) team of advisors on prioritizing frontline healthcare personnel and residents of long-term facilities for the first phase of the COVID-19 vaccine distribution.

Released: 4-Dec-2020 1:50 PM EST
COVID-19 in Victorian schools and childcare mainly driven by community transmission
Murdoch Childrens Research Institute

Analysis of Victorian data by the Murdoch Children's Research Institute suggests that COVID-19 cases in schools and childcare were mainly driven by community transmission

Released: 4-Dec-2020 12:20 PM EST
Identifying markers of COVID-19 infection using blood tests
University of Seville

Researchers from the Institute of Biomedicine of Seville (IBIS) have presented a study carried out in the Clinical Biochemistry Service of the Virgen del Rocío University Hospital which identifies the values for six biochemical biomarkers that indicate a patient may be infected with SARS-COV-2 (COVID-19).

Released: 4-Dec-2020 12:05 PM EST
Research confirms crucial monitoring assessment is effective for patients with COVID-19
University of Portsmouth

A combined research team from the Universities of Portsmouth and Bournemouth and Portsmouth Hospitals University NHS Trust has shown that an assessment score used to measure a patient's severity of illness can be applied to patients with Covid-19 without modification.

Newswise:Video Embedded flccc-alliance-calls-on-national-health-authorities-to-immediately-review-medical-evidence-showing-the-efficacy-of-ivermectin-for-the-prevention-of-covid-19-and-as-an-early-outpatient-treatment
VIDEO
Released: 4-Dec-2020 12:00 PM EST
FLCCC Alliance Calls on National Health Authorities to Immediately Review Medical Evidence Showing the Efficacy of Ivermectin for the Prevention of COVID-19 and as an Early Outpatient Treatment
Front Line COVID-19 Critical Care Alliance (FLCCC Alliance)

“Following the swi. review— and subsequent guidance— by the NIH and theCDC of Ivermectin, we expect that Ivermectin’s widespread, immediate use willallow for a rapid and safe re-opening of businesses and schools across the nation—and quickly reduce the strain on overwhelmed ICUs.” —FLCCC Alliance

Released: 4-Dec-2020 11:50 AM EST
Immunity passports: Ethical conflict and opportunity
University of the Basque Country

Immunity passports are a means of registering whether an individual has developed immunity to COVID-19 and is therefore unlikely to either catch or spread the disease.


Showing results

110 of 4219

close
2.31223